Yury Morozov | Neuroscience | Innovative Research Award

Published on by Cell Biologist

Innovative Research Award

Yury Morozov
Yale School of Medicine, Department of Neuroscience, United States

Yury Morozov
Affiliation Yale School of Medicine, Department of Neuroscience
Country United States
Scopus ID 12243546400
Documents 47
Citations 3,747
h-index 28
Subject Area Neuroscience
Event World Cell Biologist Awards
ORCID 0000-0002-3679-6819

Yury Morozov is a researcher affiliated with the Department of Neuroscience at Yale School of Medicine in the United States. His academic profile is associated with neuroscience research and scholarly contributions reflected in indexed publication and citation records. According to the supplied bibliometric information, his research portfolio comprises 47 documents, 3,747 citations, and an h-index of 28. His profile is presented in connection with the Innovative Research Award of the World Cell Biologist Awards, recognizing research contributions and their relevance to the broader scientific community. [1]

Abstract

This academic recognition profile presents the research background and bibliometric information of Yury Morozov, affiliated with the Department of Neuroscience at Yale School of Medicine, United States. His scholarly record includes 47 indexed documents, 3,747 citations, and an h-index of 28, according to the information supplied for this profile. The article outlines his institutional affiliation, research domain, publication record, scholarly visibility, and relevance to the Innovative Research Award presented by the World Cell Biologist Awards. The profile provides an overview of research recognition within the wider context of neuroscience and biomedical investigation. [1] [2]

Keywords

Yury Morozov; Innovative Research Award; Neuroscience; Yale School of Medicine; Department of Neuroscience; Biomedical Research; Scientific Publications; Research Impact; Citation Analysis; Academic Recognition; World Cell Biologist Awards.

Introduction

Neuroscience is an interdisciplinary scientific field concerned with the structure, function, development, and organization of the nervous system. It integrates molecular biology, cellular biology, physiology, genetics, computational methods, and clinical investigation to understand neural processes and their implications for health and disease. Research in this area contributes to the development of scientific knowledge concerning brain function, neural communication, and neurological conditions. [1] [3]

Research Profile

Yury Morozov’s academic affiliation is the Department of Neuroscience at Yale School of Medicine. His stated subject area is neuroscience, a broad discipline encompassing the study of nervous system organization, neural development, cellular processes, and functional mechanisms. Institutional affiliation and indexed author information provide a framework for identifying scholarly contributions and examining research activity across publications. [2] [3]

Research Contributions

Research contributions in neuroscience can span multiple levels of biological organization, from molecular and cellular mechanisms to neural circuits and integrated nervous system functions. The field depends on experimental approaches, quantitative analysis, and interdisciplinary collaboration to investigate complex biological questions. [2]

Publications

The supplied Scopus profile information reports 47 documents associated with Yury Morozov. Publication records provide an important basis for evaluating research activity, scholarly collaboration, and the dissemination of scientific findings. The Scopus author profile is the principal reference point for examining the indexed publication list and associated citation information. [5]

Research Impact

Research impact can be assessed through several complementary indicators, including publication output, citation activity, scholarly collaboration, methodological contributions, and the influence of research findings on subsequent investigations. Citation metrics provide quantitative evidence of how frequently indexed publications are cited within scholarly literature, but they should not be treated as a complete measure of scientific quality or societal impact.

The supplied profile reports 3,747 citations and an h-index of 28 across 47 documents. The h-index represents a relationship between publication output and citation frequency, indicating that at least 28 publications have received 28 or more citations, provided the figures correspond to the same database snapshot and author record. These indicators offer a quantitative overview of scholarly visibility in the indexed literature. [4]

Award Suitability

The Innovative Research Award of the World Cell Biologist Awards is associated with the recognition of research activity, scientific contributions, and innovation across relevant biomedical and life science disciplines. Neuroscience represents an important research domain within biomedical science, with connections to cellular mechanisms, molecular processes, neural function, and neurological investigation.

Yury Morozov’s supplied academic profile identifies his institutional affiliation, subject area, publication output, and citation indicators. These details provide relevant background for an academic recognition profile. A complete award assessment should additionally examine the originality of specific research findings, documented contributions, publication quality, and the candidate’s demonstrated influence within the relevant scientific field. [4]

Conclusion

Yury Morozov’s academic profile reflects an association with the Department of Neuroscience at Yale School of Medicine in the United States. The supplied bibliometric information records 47 documents, 3,747 citations, and an h-index of 28 in the subject area of neuroscience. These indicators provide a quantitative overview of his indexed scholarly activity and form part of the academic information presented in connection with the Innovative Research Award of the World Cell Biologist Awards. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Yury Morozov, Author ID 12243546400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12243546400
  2. K Pattabiraman, SK Muchnik, N Kaur, YM Morozov, et al. (2021). Hominini-specific regulation of CBLN2 increases prefrontal spinogenesis.
    https://www.nature.com/articles/s41586-021-03952-y
  3. SN Leslie, M Wang, YM Morozov, et al. (2021). Age‐related calcium dysregulation linked with tau pathology and impaired cognition in non‐human primates.
    https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12325
  4. D Franjic, M Skarica, S Ma, YM Morozov, et al. (2022). Transcriptomic taxonomy and neurogenic trajectories of adult human, macaque, and pig hippocampal and entorhinal cells.
    https://medicine.yale.edu/
  5. VC Galvin, J Solder, F Luo, YM Morozov, et al. (2019). Noradrenergic α1-adrenoceptor actions in the primate dorsolateral prefrontal cortex.
    https://www.jneurosci.org/content/39/14/2722.abstract

Yuan Zhang | Neuronal Cell Biology | Best Academic Researcher Award

Published on by Cell Biologist

Prof. Yuan Zhang | Neuronal Cell Biology | Best Academic Researcher Award

Prof. Yuan Zhang | Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University | China

Dr. Yuan Zhang, MD, Ph.D., is an accomplished neuroscientist and Associate Professor in the Department of Neurosurgery at Shenzhen Second People’s Hospital, affiliated with Shenzhen University. With over 15 years of combined experience in clinical neuroscience, academic teaching, and translational research, Dr. Zhang has carved a niche in the fields of cerebral ischemia, neurodegeneration, and brain metabolism. Her work has been pivotal in uncovering molecular mechanisms underlying stroke and Alzheimer’s disease. A dedicated scholar, Dr. Zhang has authored over 10 peer-reviewed articles in reputable international journals, often serving as lead or corresponding author. Her research is distinguished by its integration of advanced technologies such as mass spectrometry and molecular imaging with fundamental neurobiology. Dr. Zhang is committed to improving patient outcomes through a synergistic blend of laboratory research and clinical application, and she continues to lead multi-disciplinary teams in high-impact neurology projects across China.

Publication Profile: 

Scopus

Education:

Dr. Yuan Zhang began her medical journey with a Bachelor’s degree in Clinical Medicine from Baotou Medical College, where she developed a foundational understanding of human physiology and diagnostics. She furthered her studies with a Master’s in Biochemistry and Molecular Biology from the same institution, focusing on cellular mechanisms and molecular interactions. Driven by a passion for uncovering complex pathological processes, she pursued and obtained her Ph.D. in Pathology and Pathophysiology from the prestigious Peking Union Medical College, a leading institution in medical research in China. Her doctoral studies laid the groundwork for her ongoing research into the molecular basis of neurological diseases. Dr. Zhang’s robust academic foundation across medicine, molecular biology, and pathology uniquely positions her to bridge the gap between clinical practice and laboratory research, making significant contributions to the fields of stroke recovery, neuroinflammation, and neurodegenerative diseases.

Professional Experience:

Dr. Yuan Zhang has accumulated a wealth of professional experience over nearly two decades. She has served as a Researcher and Associate Professor at Shenzhen Second People’s Hospital and the First Affiliated Hospital of Shenzhen University, where she leads key neurosurgery-related research. She worked as a postdoctoral researcher at the Shenzhen Institutes of Advanced Technology under the Chinese Academy of Sciences, engaging in cutting-edge neuroscience projects. Concurrently, she served as an Associate Professor at Baotou Medical College, having previously held roles as Lecturer and Teaching Assistant. Dr. Zhang has played crucial roles in mentoring young researchers, guiding postgraduates, and fostering collaborative projects. Her clinical insights as a physician combined with her academic depth as a researcher make her an asset to both the scientific and medical communities, contributing meaningfully to translational research in neuroscience and neurosurgery.

Research Focus:

Dr. Yuan Zhang’s research focuses on elucidating the molecular mechanisms underlying cerebral ischemia, neuroinflammation, neurodegenerative disorders, and metabolic dysfunctions in the brain. She specializes in identifying potential therapeutic targets for conditions like ischemic stroke, Alzheimer’s disease, and diabetic cognitive impairment. Her interdisciplinary approach integrates molecular biology, proteomics, lipidomics, pharmacology, and neuroimaging, allowing her to study brain injury at multiple biological scales. Her recent work involves leveraging mass spectrometry and nanomedicine to map lipid changes in early ischemic events and exploring how natural compounds such as Notoginsenoside R1 and Gypenoside LXXV modulate glucose uptake and inflammation in the brain. Dr. Zhang also investigates the role of proteins like NUF2, MMP-2, and ENOPH1 in neurological damage and recovery. Her research aims to translate molecular insights into clinical therapies, ultimately improving outcomes for patients with complex neurological disorders. She is especially known for collaborative work bridging basic science and clinical neurosurgery.

Publications Top Notes:

  1. Uncovering novel functions of NUF2 in glioblastoma and MRI-based expression prediction — Scientific Reports, 2025

  2. Mass Spectrometry-based Spatiotemporal Characterization of Lipids in Early Focal Cerebral Ischemia — Analytical and Bioanalytical Chemistry

  3. Notoginsenoside R1 attenuates cognitive deficits in diabetic Alzheimer’s disease via GLUT4-dependent neuronal glucose uptake — Phytotherapy Research

  4. Alteration of Ubiquitination in the Brain of ENOPH1 Knockout Mice after Early Ischemic Stroke — Journal of Proteome Research

  5. Adenylate kinase 4 promotes neuronal energy metabolism and mitophagy in early cerebral ischemia via Parkin/PKM2 pathway — Experimental Neurology

  6. MMP-2-mediated Scube2 degradation disrupts astrocyte-endothelial interaction via Sonic Hedgehog pathway — Journal of Neurochemistry

  7. Enolase-phosphatase 1 worsens early ischemia injury by enhancing ECM destruction and blocking ADI1-MT1-MMP interaction — Experimental Neurology

  8. Black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy — Journal of Controlled Release

  9. Gypenoside LXXV increases brain glucose uptake and improves cognitive deficits in diabetic Alzheimer’s model — Phytotherapy Research

  10.  Swell1 activation in microglia suppresses neuroinflammation and reduces ischemic brain damage — Neurobiology of Disease

Conclusion :

Dr. Yuan Zhang is an outstanding candidate for the Best Academic Researcher Award. His well-established background, robust publication record, and focus on critical neurological disorders position him as a leader in academic neurosurgery research. With a continued push toward global visibility and translational impact, Dr. Zhang is likely to remain a transformative figure in neurological sciences. His combination of clinical insight and research acumen makes him not only deserving of recognition but also a source of inspiration for the future generation of clinician-scientists.

 

 

Paola Bovolenta | Neuronal Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Paola Bovolenta | Neuronal Cell Biology | Best Researcher Award

Prof. Paola Bovolenta , CSIC , Spain

Paola Bovolenta is a distinguished researcher and director of the Centro de Biología Molecular Severo Ochoa (CBM) and the CIBERER Unit 709 in Spain. With a career spanning decades, she is an expert in morphogenesis, cell-cell communication, neurodegeneration, and eye development. Her work has notably advanced our understanding of congenital eye defects and Alzheimer’s disease, particularly through her studies on the role of SFRP1 in neuroinflammation. Paola has contributed significantly to scientific literature with groundbreaking publications and has been invited to deliver lectures at prestigious international conferences. Her research integrates molecular biology with clinical insights to unravel the molecular basis of eye and brain disorders, aiming to develop therapeutic approaches for rare diseases.

Publication Profile:

Orcid

Strengths for the Award:

  1. Pioneering Research: Paola Bovolenta’s research addresses crucial aspects of developmental biology, with a focus on the molecular mechanisms behind congenital defects, neurodegeneration, and Alzheimer’s disease. Her extensive work on gene regulatory networks in eye morphogenesis and the role of SFRP1 in neuroinflammation significantly advances our understanding of rare diseases and cognitive disorders. This impactful research contributes to both basic science and clinical applications.

  2. Leadership and Collaboration: As Director of the Centro de Biología Molecular Severo Ochoa and Head of the CIBERER Unit 709, Paola has effectively led multiple research projects that involve international collaboration. Her ability to coordinate large, multidisciplinary teams makes her an exceptional leader in the field.

  3. High-Impact Publications: Paola has authored numerous influential publications in top-tier journals such as Nature Neuroscience, Cell Reports, and Development. Her work has been recognized with multiple awards and invitations to speak at prestigious international conferences, further solidifying her reputation as a leader in the field.

  4. Innovative Research Projects: Paola’s recent projects explore critical areas such as the molecular mechanisms behind congenital eye defects, neurodegenerative diseases, and potential therapeutic targets like SFRP1. These projects are highly relevant to both scientific advancement and public health, especially in the context of rare diseases and Alzheimer’s disease.

Areas for Improvement:

  1. Broader Public Engagement: While Paola’s work is widely recognized in the scientific community, expanding her outreach to broader public and clinical audiences could further amplify the societal impact of her research. Increased communication through public lectures, media, or collaborations with health organizations could make her findings more accessible to non-specialists.

  2. Interdisciplinary Integration: While Paola has done exceptional work in cellular and molecular biology, expanding interdisciplinary collaborations—particularly in fields such as bioengineering, computational biology, or pharmacology—could enhance the translation of her research into clinical solutions.

Education:

Paola Bovolenta completed her Bachelor of Science (BS) at the University of Florence, Italy, in 1981. She then pursued her Master of Science (MS) at New York University’s School of Medicine (NYU), USA, graduating in 1984. She continued her research at NYU, earning her Ph.D. in 1986, focusing on cell biology and developmental genetics. Following her doctorate, she expanded her expertise with postdoctoral research at NYU and Columbia University, New York, from 1986 to 1988. These formative years set the stage for her future research, specializing in molecular and developmental biology, particularly related to visual system development. Her extensive education underpins her pioneering work in both basic and translational science.

Experience:

Paola Bovolenta has an extensive career in both academia and scientific research. She has held the position of Director at CBM since 2002 and heads the CIBERER Unit 709, focusing on rare diseases. Her research investigates the genetic and molecular mechanisms behind the development of the visual system, including eye morphogenesis and related inborn defects. Paola has collaborated with numerous international scientists, contributing to several high-impact studies in neurodegeneration, specifically Alzheimer’s disease. Her work includes groundbreaking research into SFRP1, a protein implicated in both neuroinflammation and cognitive decline. Additionally, she coordinates several multidisciplinary projects, emphasizing genetic networks in retinal diseases and neurodegenerative disorders. Throughout her career, Paola has been involved in teaching, mentoring, and guiding emerging researchers in the field of molecular biology, enhancing her influence in the scientific community.

Awards and Honors:

Paola Bovolenta has been recognized throughout her career for her groundbreaking contributions to molecular biology and neuroscience. Her work on SFRP1 and neuroinflammation has earned her prestigious invitations to major international congresses, including as a keynote speaker at the 18th Symposium on Neuroscience at the Armenise-Harvard Foundation. She was also invited to speak at the CNRS-Jacques Monod Conference in France, discussing eye morphogenesis and developmental brain disorders. Bovolenta’s research has been consistently published in top journals such as Nature Neuroscience and Cell Reports. Her leadership in scientific initiatives has secured substantial funding for various research projects, such as those funded by AEI and the Fundación Tatiana. She is also a contributor to several influential papers and collaborative works, earning recognition for both her leadership and pioneering research in the fields of neurodegeneration, developmental biology, and rare diseases.

Research Focus:

Paola Bovolenta’s research focuses primarily on understanding the molecular mechanisms involved in visual system development, congenital eye defects, and neurodegenerative diseases like Alzheimer’s. Her work explores the gene regulatory networks that govern eye morphogenesis and the defects that lead to inborn visual disorders. A significant area of her research is the role of SFRP1, a protein involved in neuroinflammation, and its impact on brain diseases, particularly Alzheimer’s. Paola’s current projects aim to uncover how the disruption of cell-cell communication during brain and eye development contributes to neurodegeneration. She also investigates the cellular mechanisms underlying retinal degeneration, with a particular emphasis on how neuroinflammation and synaptic dysfunction contribute to cognitive decline. By focusing on rare diseases and genetic pathways, her research aims to develop therapeutic targets for conditions that currently have limited treatment options.

Publications Top Notes:

  • SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment (2025) 🧠📖

  • SFRP1 modulates astrocyte to microglia cross-talk in acute and chronic neuroinflammation (2021) 🧠🔥

  • Sfrp1 deficiency makes retinal photoreceptors prone to degeneration (2020) 👁️🧬

  • Elevated levels of Secreted-Frizzled-Related-Protein1 contribute to Alzheimer’s disease pathogenesis (2019) 🧠💥

  • Stretching of the retinal pigment epithelium contributes to zebrafish optic cup morphogenesis (2021) 🐟👁️

  • “Diversity matters series”—The Black In Neuro movement (2022) 🌍🧠

  • Maternal vgll4a promotes blastoderm cohesion enabling yap1-mediated mechano-transduction during zebrafish epiboly (2020) 🧬🐟

Conclusion:

Paola Bovolenta is an outstanding candidate for the Research for Best Researcher Award due to her groundbreaking research, significant leadership, and dedication to improving understanding of complex neurological and developmental disorders. Her work is highly innovative, with direct implications for the diagnosis and treatment of rare diseases and neurodegenerative conditions like Alzheimer’s. With her continued leadership, Paola will undoubtedly contribute further to the advancement of both scientific knowledge and clinical practice. Her work is a model of excellence in research, and she has consistently demonstrated the ability to make meaningful, real-world contributions to the scientific community.